Serum LEAP2 Levels Across the Spectrum of Metabolic Dysfunction-Associated Fatty Liver Disease: A Potential Noninvasive Biomarker for Severity Stratification

Serum LEAP2 Levels Across the Spectrum of Metabolic Dysfunction-Associated Fatty Liver Disease: A Potential Noninvasive Biomarker for Severity Stratification

Xinyang Huang,1,* Zihao Deng,1,* Xiaozhou Li,2 Songxin Yan,3 Kunjiang Zhong,1 Fengning Yuan,4 Ligang Liu,5 Chaolin Deng,6 Tingting Liu,7 Ruizhao Zhao,1 Amin Buhe,2 Tianxiong Li,2 Hao Zhao2 1Capital Medical University, Beijing, People’s Republic of China; 2Surgery Centre of Di...

Full description

Saved in:
Bibliographic Details
Main Authors: Huang X, Deng Z, Li X, Yan S, Zhong K, Yuan F, Liu L, Deng C, Liu T, Zhao R, Buhe A, Li T, Zhao H
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
LEAP2
MAFLD
MASH
hepatic steatosis
biomarker
Online Access:https://www.dovepress.com/serum-leap2-levels-across-the-spectrum-of-metabolic-dysfunction-associ-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/serum-leap2-levels-across-the-spectrum-of-metabolic-dysfunction-associ-peer-reviewed-fulltext-article-DMSO

Similar Items